Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma

被引:27
作者
Zhao, Wen-Chao [1 ]
Zhang, Hai-Bin [1 ]
Yang, Ning [1 ]
Fu, Yong [1 ]
Qian, Wei [2 ]
Chen, Ben-Dong [1 ]
Fan, Lu-Feng [1 ]
Yang, Guang-Shun [1 ]
机构
[1] Second Mil Med Univ, Dept Hepat Surg 5, Eastern Hepatobiliary Surg Hosp, Shanghai 200438, Peoples R China
[2] Second Mil Med Univ, Dept Hlth Stat, Shanghai 200433, Peoples R China
关键词
Hepatectomy; Hepatocellular carcinoma; Multinodular; Prognosis; Treatment outcome; PERCUTANEOUS RADIOFREQUENCY ABLATION; SURGICAL RESECTION; MICROVASCULAR INVASION; CIRRHOTIC-PATIENTS; LIVER RESECTION; MANAGEMENT; TRANSPLANTATION; CHEMOEMBOLIZATION; RECURRENCE; MORTALITY;
D O I
10.3748/wjg.v18.i25.3272
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate preoperative factors associated with poor short-term outcome after resection for multinodular hepatocellular carcinoma (HCC) and to assess the contraindication of patients for surgery. METHODS: We retrospectively analyzed 162 multinodular HCC patients with Child-Pugh A liver function who underwent surgical resection. The prognostic significance of preoperative factors was investigated by univariate analysis using the log-rank test and by multivariate analysis using the Cox proportional hazards model. Each independent risk factor was then assigned points to construct a scoring model to evaluate the indication for surgical intervention. A receiver operating characteristics (ROC) curve was constructed to assess the predictive ability of this system. RESULTS: The median overall survival was 38.3 mo (range: 3-80 mo), while the median disease-free survival was 18.6 mo (range: 1-79 mo). The 1-year mortality was 14%. Independent prognostic risk factors of 1-year death included prealbumin < 170 mg/L [hazard ratio (HR): 5.531, P < 0.001], alkaline phosphatase > 129 U/L (HR: 3.252, P = 0.005), alpha fetoprotein > 20 mu g/L (HR: 7.477, P = 0.011), total tumor size > 8 cm (HR: 10.543; P < 0.001), platelet count < 100 x 10(9)/L (HR: 9.937, P < 0.001), and gamma-glutamyl transpeptidase > 64 U/L (HR: 3.791, P < 0.001). The scoring model had a strong ability to predict 1-year survival (area under ROC: 0.925, P < 0.001). Patients with a score >= 5 had significantly poorer short-term outcome than those with a score < 5 (1-year mortality: 62% vs 5%, P < 0.001; 1-year recurrence rate: 86% vs 33%, P < 0.001). Patients with score >= 5 had greater possibility of microvascular invasion (P < 0.001), poor tumor differentiation (P = 0.003), liver cirrhosis with small nodules (P < 0.001), and intraoperative blood transfusion (P = 0.010). CONCLUSION: A composite preoperative scoring model can be used as an indication of prognosis of HCC patients after surgical resection. Resection should be considered with caution in patients with a score >= 5, which indicates a contraindication for surgery. (C) 2012 Baishideng. All rights reserved.
引用
收藏
页码:3272 / 3281
页数:10
相关论文
共 38 条
[1]   Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 [J].
Altekruse, Sean F. ;
McGlynn, Katherine A. ;
Reichman, Marsha E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1485-1491
[2]   Hepatocellular carcinoma: Diagnosis and treatment [J].
Befeler, AS ;
Di Bisceglie, AM .
GASTROENTEROLOGY, 2002, 122 (06) :1609-1619
[3]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[4]   Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure [J].
Bruix, J ;
Castells, A ;
Bosch, J ;
Feu, F ;
Fuster, J ;
GarciaPagan, JC ;
Visa, J ;
Bru, C ;
Rodes, J .
GASTROENTEROLOGY, 1996, 111 (04) :1018-1022
[5]   Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot study [J].
Cucchetti, Alessandro ;
Piscaglia, Fabio ;
Grigioni, Antonia D'Errico ;
Ravaioli, Matteo ;
Cescon, Matteo ;
Zanello, Matteo ;
Grazi, Gian Luca ;
Golfieri, Rita ;
Grigioni, Walter Franco ;
Pinna, Antonio Daniele .
JOURNAL OF HEPATOLOGY, 2010, 52 (06) :880-888
[6]   Liver enzyme alteration: a guide for clinicians [J].
Giannini, EG ;
Testa, R ;
Savarino, V .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (03) :367-379
[7]   Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing nonsurgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre [J].
Grieco, A ;
Pompili, M ;
Caminiti, G ;
Miele, L ;
Covino, M ;
Alfei, B ;
Rapaccini, GL ;
Gasbarrini, G .
GUT, 2005, 54 (03) :411-418
[8]   Long-Term Outcomes After Resection Versus Transplantation for Hepatocellular Carcinoma Within UCSF Criteria [J].
Ho, Cheng-Maw ;
Lee, Po-Huang ;
Chen, Chi-Ling ;
Ho, Ming-Chih ;
Wu, Yao-Ming ;
Hu, Rey-Heng .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (03) :826-833
[9]   A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria [J].
Huang, Jiwei ;
Yan, Lvnan ;
Cheng, Zheyu ;
Wu, Hong ;
Du, Liang ;
Wang, Jinzhou ;
Xu, Yinglong ;
Zeng, Yong .
ANNALS OF SURGERY, 2010, 252 (06) :903-912
[10]   Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma [J].
Ishizawa, Takeaki ;
Hasegawa, Kiyoshi ;
Aoki, Taku ;
Takahashi, Michiro ;
Inoue, Yosuke ;
Sano, Keiji ;
Imamura, Hiroshi ;
Sugawara, Yasuhiko ;
Kokudo, Norihiro ;
Makuuchi, Masatoshi .
GASTROENTEROLOGY, 2008, 134 (07) :1908-1916